Dopamine D1, D2, D3 Receptors, Vesicular Monoamine Transporter Type-2 (VMAT2) and Dopamine Transporter (DAT) Densities in Aged Human Brain

The dopamine D1, D2, D3 receptors, vesicular monoamine transporter type-2 (VMAT2), and dopamine transporter (DAT) densities were measured in 11 aged human brains (aged 77–107.8, mean: 91 years) by quantitative autoradiography. The density of D1 receptors, VMAT2, and DAT was measured using [3H]SCH23390, [3H]dihydrotetrabenazine, and [3H]WIN35428, respectively. The density of D2 and D3 receptors was calculated using the D3-preferring radioligand, [3H]WC-10 and the D2-preferring radioligand [3H]raclopride using a mathematical model developed previously by our group. Dopamine D1, D2, and D3 receptors are extensively distributed throughout striatum; the highest density of D3 receptors occurred in the nucleus accumbens (NAc). The density of the DAT is 10–20-fold lower than that of VMAT2 in striatal regions. Dopamine D3 receptor density exceeded D2 receptor densities in extrastriatal regions, and thalamus contained a high level of D3 receptors with negligible D2 receptors. The density of dopamine D1 linearly correlated with D3 receptor density in the thalamus. The density of the DAT was negligible in the extrastriatal regions whereas the VMAT2 was expressed in moderate density. D3 receptor and VMAT2 densities were in similar level between the aged human and aged rhesus brain samples, whereas aged human brain samples had lower range of densities of D1 and D2 receptors and DAT compared with the aged rhesus monkey brain. The differential density of D3 and D2 receptors in human brain will be useful in the interpretation of PET imaging studies in human subjects with existing radiotracers, and assist in the validation of newer PET radiotracers having a higher selectivity for dopamine D2 or D3 receptors.

[1]  C. Gerfen,et al.  Modulation of striatal projection systems by dopamine. , 2011, Annual review of neuroscience.

[2]  P. Sokoloff,et al.  Functional implications of multiple dopamine receptor subtypes: the D1/D3 receptor coexistence 1 Published on the World Wide Web on 24 November 1997. 1 , 1998, Brain Research Reviews.

[3]  J. Palacios,et al.  High resolution separation methods for the determination of intact human erythropoiesis stimulating agents. A review. , 2012, Analytica chimica acta.

[4]  R. V. Van Heertum,et al.  Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[5]  John W Haycock,et al.  Marked disparity between age‐related changes in dopamine and other presynaptic dopaminergic markers in human striatum , 2003, Journal of neurochemistry.

[6]  J. Palacios,et al.  Dopamine receptors in human brain: Autoradiographic distribution of D1 sites , 1989, Neuroscience.

[7]  T Greitz,et al.  Preparation of 11C-labelled Raclopride, a new potent dopamine receptor antagonist: preliminary PET studies of cerebral dopamine receptors in the monkey. , 1985, The International journal of applied radiation and isotopes.

[8]  G. Vauquelin,et al.  Autoradiographic distribution of D3-type dopamine receptors in human brain using [3H]7-hydroxy-N,N-di-n-propyl-2-aminotetralin , 1994, Brain Research.

[9]  C. Tamminga,et al.  D2-Family receptor distribution in human postmortem tissue: an autoradiographic study , 1995, Neuroreport.

[10]  C. Halldin,et al.  Quantification of [11C]FLB 457 Binding to Extrastriatal Dopamine Receptors in the Human Brain , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[11]  Sylvain Houle,et al.  Higher Binding of the Dopamine D3 Receptor-Preferring Ligand [11C]-(+)-Propyl-Hexahydro-Naphtho-Oxazin in Methamphetamine Polydrug Users: A Positron Emission Tomography Study , 2012, The Journal of Neuroscience.

[12]  M. Schäfer,et al.  The vesicular amine transporter family (SLC18): amine/proton antiporters required for vesicular accumulation and regulated exocytotic secretion of monoamines and acetylcholine , 2004, Pflügers Archiv.

[13]  Andrew M. Novick,et al.  Strain differences in the expression of dopamine D1 receptors in Wistar-Kyoto (WKY) and Wistar rats. , 2008, Life sciences.

[14]  M. Martres,et al.  Identification, characterization, and localization of the dopamine D3 receptor in rat brain using 7-[3H]hydroxy-N,N-di-n-propyl-2-aminotetralin. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[15]  J. Palacios,et al.  Mapping dopamine receptors in the human brain. , 1988, Journal of neural transmission. Supplementum.

[16]  H. Braak,et al.  Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry , 2006, Acta Neuropathologica.

[17]  J. Palacios,et al.  Dopamine receptors in human brain: Autoradiographic distribution of D2 sites , 1989, Neuroscience.

[18]  Christer Halldin,et al.  PET Mapping of Extrastriatal D2-like Dopamine Receptors in the Human Brain Using an Anatomic Standardization Technique and [11C]FLB 457 , 1999, NeuroImage.

[19]  M. Kaufman,et al.  Distribution of cocaine recognition sites in monkey brain: I. In vitro autoradiography with [3H]CFT , 1991, Synapse.

[20]  D. Surmeier,et al.  Coordinated Expression of Dopamine Receptors in Neostriatal Medium Spiny Neurons , 1996, The Journal of Neuroscience.

[21]  New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems. , 2008, Bioorganic & medicinal chemistry letters.

[22]  R. Felder,et al.  D3 Dopamine Receptor Directly Interacts With D1 Dopamine Receptor in Immortalized Renal Proximal Tubule Cells , 2006, Hypertension.

[23]  B. Christian,et al.  11C-Fallypride: radiosynthesis and preliminary evaluation of a novel dopamine D2/D3 receptor PET radiotracer in non-human primate brain. , 2004, Bioorganic & medicinal chemistry.

[24]  D. Sibley,et al.  Anterior pituitary dopamine receptors. Demonstration of interconvertible high and low affinity states of the D-2 dopamine receptor. , 1982, The Journal of biological chemistry.

[25]  J. Palacios,et al.  Visualization of dopamine D1, D2 and D3 receptor mRNA's in human and rat brain , 1992, Neurochemistry International.

[26]  P. Sokoloff,et al.  D3 dopamine receptor mRNA is widely expressed in the human brain , 1998, Brain Research.

[27]  N. Volkow,et al.  Effects of chronic cocaine abuse on postsynaptic dopamine receptors. , 1990, The American journal of psychiatry.

[28]  M. Kaufman,et al.  Autoradiographic localization of cocaine binding sites by [3H]CFT ([3H]WIN 35,428) in the monkey brain , 1990, Synapse.

[29]  J. Joyce,et al.  Distribution of Dopamine D3 Receptor Expressing Neurons in the Human Forebrain: Comparison with D2 Receptor Expressing Neurons , 1999, Neuropsychopharmacology.

[30]  B. Bloch,et al.  Expression of the d3 dopamine receptor in peptidergic neurons of the nucleus accumbens: Comparison with the D1 and D2 dopamine receptors , 1996, Neuroscience.

[31]  J. Seamans,et al.  Dopamine Receptor Signaling , 2004, Journal of receptor and signal transduction research.

[32]  B. Scatton,et al.  Autoradiographic localization of D1 dopamine receptors in the rat brain with [3H]SKF 38393. , 1985, European journal of pharmacology.

[33]  Stanley J Watson,et al.  Dopamine Receptor mRNA Expression in Human Striatum and Neocortex , 1996, Neuropsychopharmacology.

[34]  A. Lammertsma,et al.  In vivo quantification of striatal dopamine D2 receptor occupancy by JNJ-37822681 using [11C]raclopride and positron emission tomography , 2012, Journal of psychopharmacology.

[35]  H. Braak,et al.  Age, neurofibrillary changes, A beta-amyloid and the onset of Alzheimer's disease. , 1996, Neuroscience letters.

[36]  Kevin J Black,et al.  Characterization of extrastriatal D2 in vivo specific binding of [18F](N‐methyl)benperidol using PET , 2012, Synapse.

[37]  T. Di Paolo,et al.  Associative and limbic regions of monkey striatum express high levels of dopamine D3 receptors: effects of MPTP and dopamine agonist replacement therapies , 1998, The European journal of neuroscience.

[38]  V Kaasinen,et al.  Extrastriatal dopamine D2 and D3 receptors in early and advanced Parkinson’s disease , 2000, Neurology.

[39]  M. Mintun,et al.  [3H]4‐(Dimethylamino)‐N‐[4‐(4‐(2‐methoxyphenyl)piperazin‐ 1‐yl)butyl]benzamide, a selective radioligand for dopamine D3 receptors. I. In vitro characterization , 2009, Synapse.

[40]  Frank Roels,et al.  Autoradiographic localization of D1 and D2 dopamine receptors in the human brain , 1988, Neuroscience Letters.

[41]  R. Narendran,et al.  Dopamine (D2/3) receptor agonist positron emission tomography radiotracer [11C]‐(+)‐PHNO is a D3 receptor preferring agonist in vivo , 2006, Synapse.

[42]  J. Palacios,et al.  Dopamine receptors in human brain: autoradiographic distribution of D1 and D2 sites in Parkinson syndrome of different etiology , 1989, Brain Research.

[43]  John D. Beaver,et al.  Imaging Dopamine D3 Receptors in the Human Brain with Positron Emission Tomography, [11C]PHNO, and a Selective D3 Receptor Antagonist , 2010, Biological Psychiatry.

[44]  R. De La Garza,et al.  Non‐amine dopamine transporter probe [3H]tropoxene distributes to dopamine‐rich regions of monkey brain , 1999, Synapse.

[45]  E. Bézard,et al.  The dopamine D3 receptor: a therapeutic target for the treatment of neuropsychiatric disorders. , 2006, CNS & neurological disorders drug targets.

[46]  M. Laruelle,et al.  Striatal and Extrastriatal Dopamine D2/D3 Receptors in Schizophrenia Evaluated With [18F]fallypride Positron Emission Tomography , 2010, Biological Psychiatry.

[47]  J. Holden,et al.  Age‐dependent decline of dopamine D1 receptors in human brain: A PET study , 1998, Synapse.

[48]  R. Mach,et al.  No Differential Regulation of Dopamine Transporter (DAT) and Vesicular Monoamine Transporter 2 (VMAT2) Binding in a Primate Model of Parkinson Disease , 2012, PloS one.

[49]  K. Fuxe,et al.  Identification of Dopamine D1–D3 Receptor Heteromers , 2008, Journal of Biological Chemistry.

[50]  Y. Agid,et al.  [3H]Dihydrotetrabenazine, a New In Vitro Monoaminergic Probe for Human Brain , 1988, Journal of neurochemistry.

[51]  S Tanada,et al.  Age-related reduction of extrastriatal dopamine D2 receptor measured by PET. , 2001, Life sciences.

[52]  Mark Slifstein,et al.  In vivo quantification of regional dopamine‐D3 receptor binding potential of (+)‐PHNO: Studies in non‐human primates and transgenic mice , 2009, Synapse.

[53]  C. Halldin,et al.  Decreased thalamic D2/D3 receptor binding in drug-naive patients with schizophrenia: a PET study with [11C]FLB 457. , 2003, The international journal of neuropsychopharmacology.

[54]  M. Ramírez,et al.  Estado de hidratación y capacidad aeróbica: sus efectos sobre el volumen plasmático durante el ejercicio físico agudo , 2005 .

[55]  R. Mach,et al.  Progress in developing D3 dopamine receptor ligands as potential therapeutic agents for neurological and neuropsychiatric disorders. , 2003, Current pharmaceutical design.

[56]  J S Fowler,et al.  Effects of methylphenidate on regional brain glucose metabolism in humans: relationship to dopamine D2 receptors. , 1997, The American journal of psychiatry.

[57]  V. Sossi,et al.  Dopamine transporter PET in normal aging: Dopamine transporter decline and its possible role in preservation of motor function , 2010, Synapse.

[58]  J S Fowler,et al.  Role of dopamine in drug reinforcement and addiction in humans: results from imaging studies. , 2002, Behavioural pharmacology.

[59]  B. O'dowd,et al.  Deletion of dopamine D1 and D3 receptors differentially affects spontaneous behaviour and cocaine‐induced locomotor activity, reward and CREB phosphorylation , 2005, The European journal of neuroscience.

[60]  H. Braak,et al.  Age, neurofibrillary changes, Aβ-amyloid and the onset of Alzheimer's disease , 1996, Neuroscience Letters.

[61]  P. Sokoloff,et al.  Involvement of the direct striatonigral pathway in levodopa‐induced sensitization in 6‐hydroxydopamine‐lesioned rats , 2000, The European journal of neuroscience.

[62]  M. Savasta,et al.  Autoradiographic localization of D1 dopamine receptors in the rat brain with [3H]SCH 23390 , 1986, Brain Research.

[63]  P. Sokoloff,et al.  BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization , 2001, Nature.

[64]  U Ruotsalainen,et al.  Decrease in Human Striatal Dopamine D2 Receptor Density with Age: A PET Study with [11C]Raclopride , 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[65]  P. Spano,et al.  Reciprocal Regulation of Dopamine D1 and D3 Receptor Function and Trafficking by Heterodimerization , 2008, Molecular Pharmacology.

[66]  P. Sokoloff,et al.  Coexpression of dopamine D1 and D3 receptors in islands of Calleja and shell of nucleus accumbens of the rat: opposite and synergistic functional interactions , 1998, The European journal of neuroscience.

[67]  G. N. Bancroft,et al.  Binding of [3H]PD 128907, a Putatively Selective Ligand for the D3 Dopamine Receptor, in Rat Brain: A Receptor Binding and Quantitative Autoradiographic Study , 1998, Neuropsychopharmacology.

[68]  Sylvain Houle,et al.  High-Affinity States of Human Brain Dopamine D2/3 Receptors Imaged by the Agonist [11C]-(+)-PHNO , 2006, Biological Psychiatry.

[69]  P. Chan,et al.  Age-related decline in motor behavior and striatal dopamine transporter in cynomolgus monkeys , 2012, Journal of Neural Transmission.

[70]  J. Joyce,et al.  Visualization of dopamine D3-like receptors in human brain with [125I]epidepride. , 1992, European journal of pharmacology.

[71]  V. Dhawan,et al.  Abnormal striatal and thalamic dopamine neurotransmission , 2009, Neurology.

[72]  H. Forssberg,et al.  Age-related reduction in dopamine D1 receptors in the human brain: from late childhood to adulthood, a positron emission tomography study , 2010, Neuroscience.

[73]  P. Jenner,et al.  Dopamine D3 receptors in the basal ganglia of the common marmoset and following MPTP and l-DOPA treatment , 1996, Brain Research.

[74]  Christer Halldin,et al.  Autoradiographic localization of extrastriatal D2‐dopamine receptors in the human brain using [125I]epidepride , 1996, Synapse.

[75]  J. Joyce,et al.  Localization of dopamine D3 receptors to mesolimbic and D2 receptors to mesostriatal regions of human forebrain. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[76]  P. Spano,et al.  Dimerization of dopamine D1 and D3 receptors in the regulation of striatal function. , 2010, Current opinion in pharmacology.

[77]  B. Dawant,et al.  Dopamine D2 Receptor Levels in Striatum, Thalamus, Substantia Nigra, Limbic Regions, and Cortex in Schizophrenic Subjects , 2009, Biological Psychiatry.

[78]  J. Jankovic,et al.  Decreased [18F]Spiperone Binding in Putamen in Idiopathic Focal Dystonia , 1997, The Journal of Neuroscience.

[79]  Chin-Tu Chen,et al.  Preliminary assessment of extrastriatal dopamine D-2 receptor binding in the rodent and nonhuman primate brains using the high affinity radioligand, 18F-fallypride. , 1999, Nuclear medicine and biology.

[80]  Robert H Mach,et al.  Synthesis and in vitro binding of N-phenyl piperazine analogs as potential dopamine D3 receptor ligands. , 2005, Bioorganic & medicinal chemistry.

[81]  Miranda M. Lim,et al.  Sleep deprivation differentially affects dopamine receptor subtypes in mouse striatum , 2011, NeuroReport.

[82]  Mark Jenkinson,et al.  Imaging dopamine receptors in humans with [11C]-(+)-PHNO: Dissection of D3 signal and anatomy , 2011, NeuroImage.

[83]  Ariel Y Deutch,et al.  Distribution of Dopamine D2-Like Receptors in the Human Thalamus: Autoradiographic and PET Studies , 2004, Neuropsychopharmacology.

[84]  Jinbin Xu,et al.  [3H]4‐(dimethylamino)‐N‐(4‐(4‐(2‐methoxyphenyl)piperazin‐1‐yl) butyl)benzamide: A selective radioligand for dopamine D3 receptors. II. Quantitative analysis of dopamine D3 and D2 receptor density ratio in the caudate‐putamen , 2010, Synapse.

[85]  Sylvain Houle,et al.  Blockade of [11C](+)-PHNO binding in human subjects by the dopamine D3 receptor antagonist ABT-925. , 2010, The international journal of neuropsychopharmacology.

[86]  Bradley T. Christian,et al.  D2/D3 dopamine receptor binding with [F-18]fallypride in thalamus and cortex of patients with schizophrenia , 2006, Schizophrenia Research.